A PHASE III, RANDOMIZED, OPEN-LABEL, MULTICENTER, SAFETY AND EFFICACY STUDY TO EVALUATE NAB-PACLITAXEL (ABRAXANE®) AS MAINTENANCE TREATMENT AFTER INDUCTION WITH NAB-PACLITAXEL PLUS CARBOPLATIN IN SUBJECTS WITH SQUAMOUS CELL NON-SMALL CELL LUNG CANCER (NSCLC)

Authors
Category Primary study
Registry of TrialsEU Clinical Trials Register
Year 2015
This article has no abstract
Epistemonikos ID: 0f512bec97a9486463688f2f3a0847ed7d743190
First added on: Jan 22, 2025